Dilantin and Meridia drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dilantin (phenytoin sodium) and Meridia (sibutramine hydrochloride). Common drug interactions include convulsions among females and convulsion among males.

The phase IV clinical study analyzes what interactions people have when they take Dilantin and Meridia. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Dilantin?

Dilantin has active ingredients of phenytoin sodium. It is often used in epilepsy. eHealthMe is studying from 20,859 Dilantin users. Check the latest studies of Dilantin.

What is Meridia?

Meridia has active ingredients of sibutramine hydrochloride. It is often used in weight loss. eHealthMe is studying from 6,939 Meridia users. Check the latest studies of Meridia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

14 people who take Dilantin and Meridia together, and have interactions are studied.

Dilantin and Meridia drug interactions.

What are the common drug interactions of Dilantin and Meridia, by gender? *:

female:

  1. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  2. Crying
  3. Drug hypersensitivity
  4. Fatigue (feeling of tiredness)
  5. Febrile convulsion (a convulsion associated with a significant rise in body temperature)
  6. Head injury
  7. Hypersensitivity
  8. Hypoaesthesia (reduced sense of touch or sensation)
  9. Influenza like illness
  10. Loose stools

male:

  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  2. Sexual dysfunction (difficulty experienced by an individual or a couple during any stage of a normal sexual activity)

What are the common drug interactions of Dilantin and Meridia, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  2. Headache (pain in head)
  3. Pyrexia (fever)
  4. Accident
  5. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  6. Drug hypersensitivity
  7. Febrile convulsion (a convulsion associated with a significant rise in body temperature)
  8. Head injury
  9. Hypersensitivity
  10. Swelling

20-29:

n/a

30-39:

  1. Thirst
  2. Unexpected therapeutic effect
  3. Loose stools
  4. Sexual dysfunction (difficulty experienced by an individual or a couple during any stage of a normal sexual activity)

40-49:

  1. Influenza like illness

50-59:

  1. Appetite increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires)
  2. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  3. Crying
  4. Fatigue (feeling of tiredness)
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Myalgia (muscle pain)

60+:

  1. Headache (pain in head)

* Approximation only. Some reports may have incomplete information.

Do you take Dilantin and Meridia?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dilantin and Meridia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dilantin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Meridia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dilantin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Meridia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on phenytoin sodium and sibutramine hydrochloride (the active ingredients of Dilantin and Meridia, respectively), and Dilantin and Meridia (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: